NCT02533973View on ClinicalTrials.gov

Long-term Treatment of Scalp Psoriasis With Xamiol® Gel in a Large Adult Chinese Population

PHASE4CompletedINTERVENTIONAL
Enrollment

951

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

March 6, 2018

Study Completion Date

March 6, 2018

Conditions
Psoriasis Vulgaris
Interventions
DRUG

Xamiol® gel

DRUG

Daivonex® scalp solution

Trial Locations (1)

310009

The Second Affiliated hospital Zhejiang University School of Medicine, Hangzhou

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
collaborator

Tigermed Consulting Co., Ltd

INDUSTRY

lead

LEO Pharma

INDUSTRY